India’s genomics story is no longer a distant promise; it is fast becoming one of the most exciting growth narratives in healthcare. The country’s genomics market was valued at around USD 2.5 billion in 2025 and is expected to nearly quadruple to USD 9.5 billion by 2034, growing at about 16% annually on the back of precision medicine, better diagnostics, and falling sequencing costs. Whole-genome sequencing alone is projected to grow from USD 41.1 million in 2024 to USD 177.6 million by 2030, reflecting how quickly advanced testing is entering mainstream practice.
At the policy level, the GenomeIndia Project has given the ecosystem a decisive push. Launched in 2020, the initiative has collected more than 20,000 samples across 80-plus diverse populations and completed whole-genome sequencing for over 10,000 individuals, creating an Indian reference genome and a rich biobank for future research. This kind of population-scale effort not only plugs India’s historic under-representation in global genomic datasets, but it also provides local companies with a powerful foundation for building products tailored to Indian patients.
Against this backdrop, a cluster of home-grown companies is turning genomics from a lab science into a real-world engine for diagnostics, drug discovery, and preventive healthcare. Here are seven Indian players helping to define what the country’s genomics future will look like.
1. Strand Life Sciences
Strand Life Sciences is a genomics-driven research and diagnostic company with over 25 years of experience in computational biology and clinical genomics. The company combines advanced wet-lab capabilities with a strong bioinformatics foundation, anchored by proprietary platforms such as Strand NGS and StrandOmics, which are widely adopted tools with more than 25,000 global citations. Strand’s integrated approach spans clinical diagnostics, research collaborations, and precision medicine, supported by CAP- and NABL-accredited laboratories and a broad hospital partner network. Beyond clinical applications, Strand also extends its expertise to drug discovery, translational research, and multi-species genomics, enabling insights across human, microbial, and other biological systems. By enabling scalable analysis across genomics and multi-omics datasets, Strand helps translate complex sequencing data into clinically actionable insights for healthcare providers, researchers, and pharmaceutical partners worldwide.
2. MedGenome
MedGenome has emerged as one of India’s best-known clinical genomics companies, with a strong footprint in oncology, rare inherited disorders, and reproductive health. The company has created one of the largest genomics datasets in the region and supports more than 1,000 research citations globally. Its recent work on RNA-based next-generation sequencing for soft-tissue and bone sarcomas, for instance, has shown how indigenous platforms can sharpen diagnoses, uncover ultra-rare gene fusions, and influence therapy choices for complex cancers. By combining diagnostics with research collaborations, MedGenome is helping move precision oncology from niche to standard of care in India.
3 Mapmygenome
Mapmygenome is focused on consumers and preventive care, positioning genomics as a lifestyle and wellness tool rather than something patients encounter only after a diagnosis. The company offers genetic tests that provide personalized insights on fitness, nutrition, disease risk, and medication response, and has also moved into microbiome-based solutions. By combining AI-driven analytics with genetic counseling, Mapmygenome is trying to make genomics more conversational and less intimidating for first-time users.
4. SciGenom Labs
SciGenom Labs operates as a genomics innovation hub, working across healthcare, agriculture, and basic research, and is known for incubating companies such as MedGenome. Its model blends contract research, platform development, and venture-building, allowing promising ideas to move from exploratory studies to scalable businesses. By offering end-to-end genomics and next-generation sequencing services, SciGenom supports drug discovery programs, agrigenomics projects, and clinical research collaborations in India and abroad.
5. Nucleome Informatics
Nucleome Informatics focuses on AI-enabled genomics and bioinformatics services, with strong capabilities in next-generation sequencing and large-scale data analytics. The company supports both clinical diagnostics and research projects, helping institutions process and interpret complex datasets that would otherwise overwhelm in-house teams.
6. Genovation Diagnostic
Genovation Diagnostic represents the new wave of clinical genomics players bringing sophisticated tests such as whole-genome sequencing and prenatal screening into routine care settings. By offering a range of clinical-grade assays, the company contributes to early disease detection, especially in areas like hereditary conditions and reproductive health. For hospitals and clinicians, partners like Genovation make it easier to integrate genomic reports into standard diagnostic workflows, improving both speed and accuracy of decision-making.
7. Gevanam Genomics
Gevanam Genomics focuses on bioinformatics training, research support, and genomics services, helping students and early-career professionals build hands-on skills. By running specialized programs on sequencing, data analysis, and clinical interpretation, Gevanam is helping create the human capital that hospitals, startups, and research institutions will depend on as genomics becomes embedded in everyday healthcare. Its role complements national initiatives like GenomeIndia by ensuring that the data being generated can actually be analyzed and applied at scale, rather than remaining locked in specialized silos.
India’s genomics revolution is still in its early chapters, but the trajectory is clear: a fast-growing market, a strong push from national projects like GenomeIndia, and a cohort of ambitious companies working across the value chain, from sequencing and software to consumer health and education. As awareness rises and test prices fall, genomics is set to move from a niche specialist service to an integral part of India’s healthcare system, with these seven companies among those leading the way.
